CE-marked rapid self-test kit for simultaneous detection of SARS-CoV-2, Influenza A+B, and RSV with 92.9%+ sensitivity. Delivers point-of-care respiratory diagnostics using fluorescence immunoassay technology for clinical and home-based testing environments.
Manufactured by
Shenzhen Microprofit Biotech Co., Ltd
Shenzhen, China
Headquartered in Microprofit Building, Shenzhen, Microprofit Biotech was established in 2009. As a national-level high-tech enterprise, we specialize in the integrated production, research, and sales of cutting-edge IVD products with our own GMP Workshop. With our independent brand, fluorecare®, our products have gained popularity in 100+ countries and regions. We prioritize quality and focus on the field of in-vitro diagnostics, striving to create a new impact on point-of-care testing (POCT) and benefit healthcare professionals and patients worldwide. Embracing technological innovation, we aim to make a difference in people's lives.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 1 relevant product
Healgen Scientific LLC
United States · 3 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 7 relevant products
67 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 118 closest product alternatives
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Rapid antigen self-test kit for simultaneous detection of SARS-CoV-2, Influenza A and B, and RSV from respiratory or blood specimens. Designed for point-of-care testing with simplified workflow enabling quick identification of multiple respiratory pathogens in clinical and home settings.
Healgen Scientific LLC · United States
CLIA-waived PCR detection kit for simultaneous identification of SARS-CoV-2 and Influenza A/B using direct fluorescence technology. Enables rapid respiratory pathogen screening in clinical and point-of-care settings with streamlined sample-to-result workflow.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Rapid lateral flow immunoassay (LFIA) for simultaneous qualitative detection of SARS-CoV-2, influenza A and B, adenovirus, respiratory syncytial virus, and Streptococcus A antigens. Designed for point-of-care respiratory pathogen screening in clinical and self-testing settings.
115 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products